Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso

(1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the healt...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Massa dit Achille Bonko [verfasserIn] Palpouguini Lompo [verfasserIn] Marc Christian Tahita [verfasserIn] Francois Kiemde [verfasserIn] Ibrahima Karama [verfasserIn] Athanase M. Somé [verfasserIn] Petra F. Mens [verfasserIn] Sandra Menting [verfasserIn] Halidou Tinto [verfasserIn] Henk D. F. H. Schallig [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2021

Schlagwörter:	antibiotics resistance nasopharynx children

Übergeordnetes Werk:	In: Antibiotics - MDPI AG, 2013, 10(2021), 4, p 444
Übergeordnetes Werk:	volume:10 ; year:2021 ; number:4, p 444

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc

DOI / URN:	10.3390/antibiotics10040444

Katalog-ID:	DOAJ074352482

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ074352482
003	DE-627
005	20240412184040.0
007	cr uuu---uuuuu
008	230228s2021 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.3390/antibiotics10040444 \|2 doi
035			\|a (DE-627)DOAJ074352482
035			\|a (DE-599)DOAJ25625a380afa46c09898852a92221a7c
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a RM1-950
100	0		\|a Massa dit Achille Bonko \|e verfasserin \|4 aut
245	1	0	\|a Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso
264		1	\|c 2021
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a (1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance.
650		4	\|a antibiotics
650		4	\|a resistance
650		4	\|a nasopharynx
650		4	\|a children
650		4	\|a <i<Streptococcus pneumoniae</i<
650		4	\|a <i<Staphylococcus aureus</i<
653		0	\|a Therapeutics. Pharmacology
700	0		\|a Palpouguini Lompo \|e verfasserin \|4 aut
700	0		\|a Marc Christian Tahita \|e verfasserin \|4 aut
700	0		\|a Francois Kiemde \|e verfasserin \|4 aut
700	0		\|a Ibrahima Karama \|e verfasserin \|4 aut
700	0		\|a Athanase M. Somé \|e verfasserin \|4 aut
700	0		\|a Petra F. Mens \|e verfasserin \|4 aut
700	0		\|a Sandra Menting \|e verfasserin \|4 aut
700	0		\|a Halidou Tinto \|e verfasserin \|4 aut
700	0		\|a Henk D. F. H. Schallig \|e verfasserin \|4 aut
773	0	8	\|i In \|t Antibiotics \|d MDPI AG, 2013 \|g 10(2021), 4, p 444 \|w (DE-627)726120596 \|w (DE-600)2681345-2 \|x 20796382 \|7 nnns
773	1	8	\|g volume:10 \|g year:2021 \|g number:4, p 444
856	4	0	\|u https://doi.org/10.3390/antibiotics10040444 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/25625a380afa46c09898852a92221a7c \|z kostenfrei
856	4	0	\|u https://www.mdpi.com/2079-6382/10/4/444 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2079-6382 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 10 \|j 2021 \|e 4, p 444

Indexfelder

author_variant	m d a b mdab p l pl m c t mct f k fk i k ik a m s ams p f m pfm s m sm h t ht h d f h s hdfhs
matchkey_str	article:20796382:2021----::niitcucpiiiyfsahlccuaruinitetccupemnaisltsrmhnspayxferl
hierarchy_sort_str	2021
callnumber-subject-code	RM
publishDate	2021
allfields	10.3390/antibiotics10040444 doi (DE-627)DOAJ074352482 (DE-599)DOAJ25625a380afa46c09898852a92221a7c DE-627 ger DE-627 rakwb eng RM1-950 Massa dit Achille Bonko verfasserin aut Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier (1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i< Therapeutics. Pharmacology Palpouguini Lompo verfasserin aut Marc Christian Tahita verfasserin aut Francois Kiemde verfasserin aut Ibrahima Karama verfasserin aut Athanase M. Somé verfasserin aut Petra F. Mens verfasserin aut Sandra Menting verfasserin aut Halidou Tinto verfasserin aut Henk D. F. H. Schallig verfasserin aut In Antibiotics MDPI AG, 2013 10(2021), 4, p 444 (DE-627)726120596 (DE-600)2681345-2 20796382 nnns volume:10 year:2021 number:4, p 444 https://doi.org/10.3390/antibiotics10040444 kostenfrei https://doaj.org/article/25625a380afa46c09898852a92221a7c kostenfrei https://www.mdpi.com/2079-6382/10/4/444 kostenfrei https://doaj.org/toc/2079-6382 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 444
spelling	10.3390/antibiotics10040444 doi (DE-627)DOAJ074352482 (DE-599)DOAJ25625a380afa46c09898852a92221a7c DE-627 ger DE-627 rakwb eng RM1-950 Massa dit Achille Bonko verfasserin aut Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier (1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i< Therapeutics. Pharmacology Palpouguini Lompo verfasserin aut Marc Christian Tahita verfasserin aut Francois Kiemde verfasserin aut Ibrahima Karama verfasserin aut Athanase M. Somé verfasserin aut Petra F. Mens verfasserin aut Sandra Menting verfasserin aut Halidou Tinto verfasserin aut Henk D. F. H. Schallig verfasserin aut In Antibiotics MDPI AG, 2013 10(2021), 4, p 444 (DE-627)726120596 (DE-600)2681345-2 20796382 nnns volume:10 year:2021 number:4, p 444 https://doi.org/10.3390/antibiotics10040444 kostenfrei https://doaj.org/article/25625a380afa46c09898852a92221a7c kostenfrei https://www.mdpi.com/2079-6382/10/4/444 kostenfrei https://doaj.org/toc/2079-6382 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 444
allfields_unstemmed	10.3390/antibiotics10040444 doi (DE-627)DOAJ074352482 (DE-599)DOAJ25625a380afa46c09898852a92221a7c DE-627 ger DE-627 rakwb eng RM1-950 Massa dit Achille Bonko verfasserin aut Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier (1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i< Therapeutics. Pharmacology Palpouguini Lompo verfasserin aut Marc Christian Tahita verfasserin aut Francois Kiemde verfasserin aut Ibrahima Karama verfasserin aut Athanase M. Somé verfasserin aut Petra F. Mens verfasserin aut Sandra Menting verfasserin aut Halidou Tinto verfasserin aut Henk D. F. H. Schallig verfasserin aut In Antibiotics MDPI AG, 2013 10(2021), 4, p 444 (DE-627)726120596 (DE-600)2681345-2 20796382 nnns volume:10 year:2021 number:4, p 444 https://doi.org/10.3390/antibiotics10040444 kostenfrei https://doaj.org/article/25625a380afa46c09898852a92221a7c kostenfrei https://www.mdpi.com/2079-6382/10/4/444 kostenfrei https://doaj.org/toc/2079-6382 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 444
allfieldsGer	10.3390/antibiotics10040444 doi (DE-627)DOAJ074352482 (DE-599)DOAJ25625a380afa46c09898852a92221a7c DE-627 ger DE-627 rakwb eng RM1-950 Massa dit Achille Bonko verfasserin aut Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier (1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i< Therapeutics. Pharmacology Palpouguini Lompo verfasserin aut Marc Christian Tahita verfasserin aut Francois Kiemde verfasserin aut Ibrahima Karama verfasserin aut Athanase M. Somé verfasserin aut Petra F. Mens verfasserin aut Sandra Menting verfasserin aut Halidou Tinto verfasserin aut Henk D. F. H. Schallig verfasserin aut In Antibiotics MDPI AG, 2013 10(2021), 4, p 444 (DE-627)726120596 (DE-600)2681345-2 20796382 nnns volume:10 year:2021 number:4, p 444 https://doi.org/10.3390/antibiotics10040444 kostenfrei https://doaj.org/article/25625a380afa46c09898852a92221a7c kostenfrei https://www.mdpi.com/2079-6382/10/4/444 kostenfrei https://doaj.org/toc/2079-6382 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 444
allfieldsSound	10.3390/antibiotics10040444 doi (DE-627)DOAJ074352482 (DE-599)DOAJ25625a380afa46c09898852a92221a7c DE-627 ger DE-627 rakwb eng RM1-950 Massa dit Achille Bonko verfasserin aut Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier (1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i< Therapeutics. Pharmacology Palpouguini Lompo verfasserin aut Marc Christian Tahita verfasserin aut Francois Kiemde verfasserin aut Ibrahima Karama verfasserin aut Athanase M. Somé verfasserin aut Petra F. Mens verfasserin aut Sandra Menting verfasserin aut Halidou Tinto verfasserin aut Henk D. F. H. Schallig verfasserin aut In Antibiotics MDPI AG, 2013 10(2021), 4, p 444 (DE-627)726120596 (DE-600)2681345-2 20796382 nnns volume:10 year:2021 number:4, p 444 https://doi.org/10.3390/antibiotics10040444 kostenfrei https://doaj.org/article/25625a380afa46c09898852a92221a7c kostenfrei https://www.mdpi.com/2079-6382/10/4/444 kostenfrei https://doaj.org/toc/2079-6382 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 444
language	English
source	In Antibiotics 10(2021), 4, p 444 volume:10 year:2021 number:4, p 444
sourceStr	In Antibiotics 10(2021), 4, p 444 volume:10 year:2021 number:4, p 444
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i< Therapeutics. Pharmacology
isfreeaccess_bool	true
container_title	Antibiotics
authorswithroles_txt_mv	Massa dit Achille Bonko @@aut@@ Palpouguini Lompo @@aut@@ Marc Christian Tahita @@aut@@ Francois Kiemde @@aut@@ Ibrahima Karama @@aut@@ Athanase M. Somé @@aut@@ Petra F. Mens @@aut@@ Sandra Menting @@aut@@ Halidou Tinto @@aut@@ Henk D. F. H. Schallig @@aut@@
publishDateDaySort_date	2021-01-01T00:00:00Z
hierarchy_top_id	726120596
id	DOAJ074352482
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ074352482</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240412184040.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2021 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/antibiotics10040444</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ074352482</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ25625a380afa46c09898852a92221a7c</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Massa dit Achille Bonko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">(1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antibiotics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">resistance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">nasopharynx</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">children</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Streptococcus pneumoniae</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Staphylococcus aureus</i<</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Palpouguini Lompo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marc Christian Tahita</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Francois Kiemde</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ibrahima Karama</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Athanase M. Somé</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Petra F. Mens</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sandra Menting</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Halidou Tinto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Henk D. F. H. Schallig</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Antibiotics</subfield><subfield code="d">MDPI AG, 2013</subfield><subfield code="g">10(2021), 4, p 444</subfield><subfield code="w">(DE-627)726120596</subfield><subfield code="w">(DE-600)2681345-2</subfield><subfield code="x">20796382</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:4, p 444</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/antibiotics10040444</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/25625a380afa46c09898852a92221a7c</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2079-6382/10/4/444</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2079-6382</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2021</subfield><subfield code="e">4, p 444</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Massa dit Achille Bonko
spellingShingle	Massa dit Achille Bonko misc RM1-950 misc antibiotics misc resistance misc nasopharynx misc children misc <i<Streptococcus pneumoniae</i< misc <i<Staphylococcus aureus</i< misc Therapeutics. Pharmacology Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso
authorStr	Massa dit Achille Bonko
ppnlink_with_tag_str_mv	@@773@@(DE-627)726120596
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RM1-950
illustrated	Not Illustrated
issn	20796382
topic_title	RM1-950 Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i<
topic	misc RM1-950 misc antibiotics misc resistance misc nasopharynx misc children misc <i<Streptococcus pneumoniae</i< misc <i<Staphylococcus aureus</i< misc Therapeutics. Pharmacology
topic_unstemmed	misc RM1-950 misc antibiotics misc resistance misc nasopharynx misc children misc <i<Streptococcus pneumoniae</i< misc <i<Staphylococcus aureus</i< misc Therapeutics. Pharmacology
topic_browse	misc RM1-950 misc antibiotics misc resistance misc nasopharynx misc children misc <i<Streptococcus pneumoniae</i< misc <i<Staphylococcus aureus</i< misc Therapeutics. Pharmacology
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Antibiotics
hierarchy_parent_id	726120596
hierarchy_top_title	Antibiotics
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)726120596 (DE-600)2681345-2
title	Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso
ctrlnum	(DE-627)DOAJ074352482 (DE-599)DOAJ25625a380afa46c09898852a92221a7c
title_full	Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso
author_sort	Massa dit Achille Bonko
journal	Antibiotics
journalStr	Antibiotics
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2021
contenttype_str_mv	txt
author_browse	Massa dit Achille Bonko Palpouguini Lompo Marc Christian Tahita Francois Kiemde Ibrahima Karama Athanase M. Somé Petra F. Mens Sandra Menting Halidou Tinto Henk D. F. H. Schallig
container_volume	10
class	RM1-950
format_se	Elektronische Aufsätze
author-letter	Massa dit Achille Bonko
doi_str_mv	10.3390/antibiotics10040444
author2-role	verfasserin
title_sort	antibiotic susceptibility of <i<staphylococcus aureus</i< and <i<streptococcus pneumoniae</i< isolates from the nasopharynx of febrile children under 5 years in nanoro, burkina faso
callnumber	RM1-950
title_auth	Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso
abstract	(1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance.
abstractGer	(1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance.
abstract_unstemmed	(1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	4, p 444
title_short	Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso
url	https://doi.org/10.3390/antibiotics10040444 https://doaj.org/article/25625a380afa46c09898852a92221a7c https://www.mdpi.com/2079-6382/10/4/444 https://doaj.org/toc/2079-6382
remote_bool	true
author2	Palpouguini Lompo Marc Christian Tahita Francois Kiemde Ibrahima Karama Athanase M. Somé Petra F. Mens Sandra Menting Halidou Tinto Henk D. F. H. Schallig
author2Str	Palpouguini Lompo Marc Christian Tahita Francois Kiemde Ibrahima Karama Athanase M. Somé Petra F. Mens Sandra Menting Halidou Tinto Henk D. F. H. Schallig
ppnlink	726120596
callnumber-subject	RM - Therapeutics and Pharmacology
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.3390/antibiotics10040444
callnumber-a	RM1-950
up_date	2024-07-03T22:40:38.794Z
_version_	1803599414605905922
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ074352482</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240412184040.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2021 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/antibiotics10040444</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ074352482</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ25625a380afa46c09898852a92221a7c</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Massa dit Achille Bonko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">(1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antibiotics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">resistance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">nasopharynx</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">children</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Streptococcus pneumoniae</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Staphylococcus aureus</i<</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Palpouguini Lompo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marc Christian Tahita</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Francois Kiemde</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ibrahima Karama</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Athanase M. Somé</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Petra F. Mens</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sandra Menting</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Halidou Tinto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Henk D. F. H. Schallig</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Antibiotics</subfield><subfield code="d">MDPI AG, 2013</subfield><subfield code="g">10(2021), 4, p 444</subfield><subfield code="w">(DE-627)726120596</subfield><subfield code="w">(DE-600)2681345-2</subfield><subfield code="x">20796382</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:4, p 444</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/antibiotics10040444</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/25625a380afa46c09898852a92221a7c</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2079-6382/10/4/444</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2079-6382</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2021</subfield><subfield code="e">4, p 444</subfield></datafield></record></collection>
score	7.40088

Nicht das Richtige dabei?

Schreiben Sie uns!

Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?